Outcomes of Prophylactic Swallowing Therapy in Patients Undergoing Definitive Chemoradiation for Head and Neck Cancer

Head and Neck Cancer Clinical Trial

Official title:

Does the Use of Clinician Directed Prophylactic Swallowing Therapy in Patients Undergoing Definitive Chemoradiation for Head and Neck Cancer Improve Swallowing Function Outcomes?

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03435471
• Other study ID #: 20180084
• Status: Completed
• Phase: N/A
• Start date: September 17, 2018
• Est. completion date: January 13, 2021

Study information

• Verified date: January 2021
• Source: University of Miami
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Clinician directed prophylactic swallowing therapy will improve immediate (four weeks +/- two weeks) and short-term (26 weeks +/- four weeks) post-treatment swallowing function and quality of life versus patient directed home exercises.

The purpose of this prospective, interventional, pilot investigation is to determine whether clinician directed swallowing therapy will improve patient swallowing function outcomes and quality of life in the immediate and short-term basis compared to patients receiving standard of care patient directed independent home swallowing therapy. Patient compliance with home exercises programs is reportedly inconsistent. Patients may experience changes in their physical functioning and overall well-being that may impact their ability to follow-through with independent home therapy. Clinician directed swallowing therapy allows for ongoing assessment of changes that may warrant modifying the therapy program in terms of intensity of exercises and/or expectations. This facilitates individualizing the patient's therapy plan to maximize their function and ability to achieve goals. It is anticipated that individualizing swallowing therapy through weekly session will result in improved swallowing function.

Description:

This is a single-site, two-arm, 1:1 randomized, prospective, interventional, pilot study to determine whether clinician directed swallowing therapy will improve patient swallowing function outcomes when compared to patient-directed home-based swallowing therapy.

The investigators anticipate at least 40 subjects will need to be enrolled/consented in order to obtain the accrual goal of 15 evaluable subjects for each group for a total of 30 participants.

All subjects in each group will receive a face-to-face education session with a speech pathologist to review a recommended program of swallowing exercises prior to initiation of chemoradiation at their baseline (pre-treatment evaluation session).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: January 13, 2021
• Est. primary completion date: July 17, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Diagnosis of head and neck cancer (sites: oropharynx: human papillomavirus (HPV) related and non HPV related tonsil and base of tongue)

2. Scheduled to undergo definitive chemoradiation therapy

3. At least 18 years of age or older

4. Subject must have the ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria:

1. Surgical management in addition to chemoradiation therapy;

2. Cancer of the sinus, brain, or parotid;

3. Prior treatment for head and neck cancer;

4. Receiving chemoradiation treatment at an outside institution (i.e., non-University of Miami (UM) clinic);

5. Prior history of dysphagia unrelated to the current diagnosis of head and neck cancer;

6. Prior neurologic disorder (i.e., Cerebrovascular accident (CVA), Traumatic brain injury (TBI), dementia) or current degenerative neuromuscular disease;

7. History of prior c-spine surgery;

8. History of prior vocal fold immobility

Related Conditions & MeSH terms

• Head and Neck Cancer
• Head and Neck Neoplasms
• Oropharyngeal Neoplasms
• Oropharynx Cancer

Intervention

Other:
• Prophylactic Swallowing Home Exercise Program
The home exercise program will consist of six exercises that are recommended to be practiced three times per day. Subjects will complete a weekly exercise log to track compliance.
• Clinician-Directed Prophylactic Swallowing Exercises
Once weekly face-to-face meetings with a study speech pathologist for a total of six sessions, to participate in active swallowing exercises

Locations

Country	Name	City	State
United States	University of Miami	Miami	Florida

Sponsors (1)

Lead Sponsor	Collaborator
University of Miami

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in swallowing status	Swallowing status will be measured using Functional Oral Intake Scale (FOIS). FOIS has a range from 0 (most restrictive) to 7 (least restrictive).	Baseline, Up to 6 weeks
Secondary	Change in swallowing status as measured by FOIS	FOIS has a range from 0 (most restrictive) to 7 (least restrictive).	Baseline, Up to 30 weeks
Secondary	Change in quality of life as measured by PSS-HN	Performance Status Scale - Head and Neck (PSS-HSN) is a questionnaire with a total score ranging from 100 (normal function) to 0 (limited function).	Baseline to 6 weeks, Baseline to 30 weeks
Secondary	Change in quality of life as measured by EAT-10	Eating Assessment Tool-10 (EAT-10) is a questionnaire with a total score ranging from 0 to 40 with the lower score indicating better function.	Baseline to 6 weeks, Baseline to 30 weeks
Secondary	Change in quality of life as measured by UW-QOL	University of Washington Quality of Life (UW-QOL) is a questionnaire with a total score ranging from 0 to 100 with the higher score indicating poorer health outcomes.	Baseline to 6 weeks, Baseline to 30 weeks
Secondary	Proportion of patients requiring further swallowing therapy	Proportion of patients requiring further swallowing therapy post study intervention as per treating physician discretion	Baseline to 6 weeks, Baseline to 30 weeks
Secondary	Change in Pharyngeal Swallowing Efficiency and Safety as measured by DIGEST Safety Grade	DIGEST is a measure of pharyngeal swallowing efficiency and safety. The DIGEST measure incorporates 2 measures: Safety as determined by the Penetration Aspiration Scale with a score ranging from 0 (safe) to 4 (life-threatening unsafe); and; Efficiency as determined by the quantity of residue observed on the videoflouroscopic swallowing study with a score ranging from 0 (efficient) to 4 (life-threatening inefficiency).; These two measures combine for an overall score, ranging from 0 (no pharyngeal dysphagia) to 4 (life-threatening dysphagia).	Baseline to 6 weeks, Baseline to 30 weeks